10x Genomics公司(股票代码:TXG)今日盘中股价大跌12.77%,引发市场广泛关注。
导致该股暴跌的主要原因是:美国国立卫生研究院计划削减约40亿美元的成本,这将给包括10x Genomics在内的生命科学技术公司带来巨大冲击。
10x Genomics是一家生物科技公司,主要从事基因测序设备的研发和生产。其主要客户是美国的学术和研究机构,而这些机构将遭受政府削减医研经费的重大冲击,因此他们预计将暂缓对仪器等设备的采购。10x Genomics作为领先的基因测序设备供应商,必将受到严重影响,销售业绩面临下滑。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.